Global Companion Diagnostics Market 2023-2027

Quick Summary:

In a swiftly evolving healthcare landscape, staying informed is paramount to success. The companion diagnostics market is seeing remarkable growth, powered by the on-going rise of personalized medicine, an increase in industry collaborations, and substantial investments in life sciences. This comprehensive market research report offers holistic and up-to-date analysis, capturing the pulse of the current market scenario, latest trends, and main growth drivers.

Divided into market segments including end-users, indications, and geographical landscapes, this report highlights the mounting occurrence of illnesses such as breast cancer, the rise in product approvals for disease treatment and the expanding role of promotional activities as key factors driving market growth. With data sourced from industry key participants and a robust vendor analysis, this report is a vital tool for any forward-thinking executive wishing to improve their market position, apply strategic foresight, and leverage upcoming growth opportunities, with insights on the future trends and challenges that will shape the market.

Market Growth Has Experienced a Change of 25.29% YoY in 2020

The companion diagnostics market is forecasted to grow by USD 11,029.63 mn during 2022-2027, accelerating at a CAGR of 22.59% during the forecast period. The report on the companion diagnostics market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising use of personalized medicine, increased industry collaborations, and growing investments in the life sciences sector.

The companion diagnostics market is segmented as below:

By End-user

Life science
Health centers
Others

By Indication

Oncology
Neurology
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, an increase in product approvals to treat cancer and the growing importance of promotional activities will lead to sizable demand in the market.

The report on the companion diagnostics market covers the following areas:

Companion diagnostics market sizing
Companion diagnostics market forecast
Companion diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Indication
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global companion diagnostics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global companion diagnostics market 2017 - 2021 ($ million)
4.2 End-user Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.3 Indication Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Life science - Market size and forecast 2022-2027
Exhibit 34: Chart on Life science - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Life science - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Life science - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Life science - Year-over-year growth 2022-2027 (%)
6.4 Health centers - Market size and forecast 2022-2027
Exhibit 38: Chart on Health centers - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Health centers - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Health centers - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Health centers - Year-over-year growth 2022-2027 (%)
6.5 Others - Market size and forecast 2022-2027
Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Indication

7.1 Market segments
Exhibit 48: Chart on Indication - Market share 2022-2027 (%)
Exhibit 49: Data Table on Indication - Market share 2022-2027 (%)
7.2 Comparison by Indication
Exhibit 50: Chart on Comparison by Indication
Exhibit 51: Data Table on Comparison by Indication
7.3 Oncology - Market size and forecast 2022-2027
Exhibit 52: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
7.4 Neurology - Market size and forecast 2022-2027
Exhibit 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Indication
Exhibit 64: Market opportunity by Indication ($ million)
Exhibit 65: Data Table on Market opportunity by Indication ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 France - Market size and forecast 2022-2027
Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ million)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 115: Abbott Laboratories - Overview
Exhibit 116: Abbott Laboratories - Business segments
Exhibit 117: Abbott Laboratories - Key news
Exhibit 118: Abbott Laboratories - Key offerings
Exhibit 119: Abbott Laboratories - Segment focus
12.4 Abnova Corp.
Exhibit 120: Abnova Corp. - Overview
Exhibit 121: Abnova Corp. - Product/Service
Exhibit 122: Abnova Corp. - Key offerings
12.5 Agilent Technologies Inc.
Exhibit 123: Agilent Technologies Inc. - Overview
Exhibit 124: Agilent Technologies Inc. - Business segments
Exhibit 125: Agilent Technologies Inc. - Key offerings
Exhibit 126: Agilent Technologies Inc. - Segment focus
12.6 Amoy Diagnostics Co. Ltd.
Exhibit 127: Amoy Diagnostics Co. Ltd. - Overview
Exhibit 128: Amoy Diagnostics Co. Ltd. - Product/Service
Exhibit 129: Amoy Diagnostics Co. Ltd. - Key offerings
12.7 ARUP Laboratories
Exhibit 130: ARUP Laboratories - Overview
Exhibit 131: ARUP Laboratories - Product/Service
Exhibit 132: ARUP Laboratories - Key offerings
12.8 Bayer AG
Exhibit 133: Bayer AG - Overview
Exhibit 134: Bayer AG - Business segments
Exhibit 135: Bayer AG - Key news
Exhibit 136: Bayer AG - Key offerings
Exhibit 137: Bayer AG - Segment focus
12.9 BioGenex Laboratories Inc.
Exhibit 138: BioGenex Laboratories Inc. - Overview
Exhibit 139: BioGenex Laboratories Inc. - Product/Service
Exhibit 140: BioGenex Laboratories Inc. - Key offerings
12.10 bioMerieux SA
Exhibit 141: bioMerieux SA - Overview
Exhibit 142: bioMerieux SA - Product/Service
Exhibit 143: bioMerieux SA - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 144: F. Hoffmann La Roche Ltd. - Overview
Exhibit 145: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 146: F. Hoffmann La Roche Ltd. - Key news
Exhibit 147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 148: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Illumina Inc.
Exhibit 149: Illumina Inc. - Overview
Exhibit 150: Illumina Inc. - Business segments
Exhibit 151: Illumina Inc. - Key news
Exhibit 152: Illumina Inc. - Key offerings
Exhibit 153: Illumina Inc. - Segment focus
12.13 Myriad Genetics Inc.
Exhibit 154: Myriad Genetics Inc. - Overview
Exhibit 155: Myriad Genetics Inc. - Product/Service
Exhibit 156: Myriad Genetics Inc. - Key offerings
12.14 QIAGEN NV
Exhibit 157: QIAGEN NV - Overview
Exhibit 158: QIAGEN NV - Product/Service
Exhibit 159: QIAGEN NV - Key news
Exhibit 160: QIAGEN NV - Key offerings
12.15 Siemens AG
Exhibit 161: Siemens AG - Overview
Exhibit 162: Siemens AG - Business segments
Exhibit 163: Siemens AG - Key news
Exhibit 164: Siemens AG - Key offerings
Exhibit 165: Siemens AG - Segment focus
12.16 Sysmex Corp.
Exhibit 166: Sysmex Corp. - Overview
Exhibit 167: Sysmex Corp. - Business segments
Exhibit 168: Sysmex Corp. - Key offerings
Exhibit 169: Sysmex Corp. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 170: Thermo Fisher Scientific Inc. - Overview
Exhibit 171: Thermo Fisher Scientific Inc. - Business segments
Exhibit 172: Thermo Fisher Scientific Inc. - Key news
Exhibit 173: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 174: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 175: Inclusions checklist
Exhibit 176: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 177: Currency conversion rates for US$
13.4 Research methodology
Exhibit 178: Research methodology
Exhibit 179: Validation techniques employed for market sizing
Exhibit 180: Information sources
13.5 List of abbreviations
Exhibit 181: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on global companion diagnostics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Indication Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on End-user - Market share 2022-2027 (%)
Exhibits 31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Life science - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Life science - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Life science - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Life science - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Health centers - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Health centers - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Health centers - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Health centers - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by End-user ($ million)
Exhibits 47: Data Table on Market opportunity by End-user ($ million)
Exhibits 48: Chart on Indication - Market share 2022-2027 (%)
Exhibits 49: Data Table on Indication - Market share 2022-2027 (%)
Exhibits 50: Chart on Comparison by Indication
Exhibits 51: Data Table on Comparison by Indication
Exhibits 52: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Neurology - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Neurology - Year-over-year growth 2022-2027 (%)
Exhibits 60: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 64: Market opportunity by Indication ($ million)
Exhibits 65: Data Table on Market opportunity by Indication ($ million)
Exhibits 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 69: Chart on Geographic comparison
Exhibits 70: Data Table on Geographic comparison
Exhibits 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 104: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 105: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 107: Market opportunity By Geographical Landscape ($ million)
Exhibits 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 109: Impact of drivers and challenges in 2022 and 2027
Exhibits 110: Overview on Criticality of inputs and Factors of differentiation
Exhibits 111: Overview on factors of disruption
Exhibits 112: Impact of key risks on business
Exhibits 113: Vendors covered
Exhibits 114: Matrix on vendor position and classification
Exhibits 115: Abbott Laboratories - Overview
Exhibits 116: Abbott Laboratories - Business segments
Exhibits 117: Abbott Laboratories - Key news
Exhibits 118: Abbott Laboratories - Key offerings
Exhibits 119: Abbott Laboratories - Segment focus
Exhibits 120: Abnova Corp. - Overview
Exhibits 121: Abnova Corp. - Product/Service
Exhibits 122: Abnova Corp. - Key offerings
Exhibits 123: Agilent Technologies Inc. - Overview
Exhibits 124: Agilent Technologies Inc. - Business segments
Exhibits 125: Agilent Technologies Inc. - Key offerings
Exhibits 126: Agilent Technologies Inc. - Segment focus
Exhibits 127: Amoy Diagnostics Co. Ltd. - Overview
Exhibits 128: Amoy Diagnostics Co. Ltd. - Product/Service
Exhibits 129: Amoy Diagnostics Co. Ltd. - Key offerings
Exhibits 130: ARUP Laboratories - Overview
Exhibits 131: ARUP Laboratories - Product/Service
Exhibits 132: ARUP Laboratories - Key offerings
Exhibits 133: Bayer AG - Overview
Exhibits 134: Bayer AG - Business segments
Exhibits 135: Bayer AG - Key news
Exhibits 136: Bayer AG - Key offerings
Exhibits 137: Bayer AG - Segment focus
Exhibits 138: BioGenex Laboratories Inc. - Overview
Exhibits 139: BioGenex Laboratories Inc. - Product/Service
Exhibits 140: BioGenex Laboratories Inc. - Key offerings
Exhibits 141: bioMerieux SA - Overview
Exhibits 142: bioMerieux SA - Product/Service
Exhibits 143: bioMerieux SA - Key offerings
Exhibits 144: F. Hoffmann La Roche Ltd. - Overview
Exhibits 145: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 146: F. Hoffmann La Roche Ltd. - Key news
Exhibits 147: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 148: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 149: Illumina Inc. - Overview
Exhibits 150: Illumina Inc. - Business segments
Exhibits 151: Illumina Inc. - Key news
Exhibits 152: Illumina Inc. - Key offerings
Exhibits 153: Illumina Inc. - Segment focus
Exhibits 154: Myriad Genetics Inc. - Overview
Exhibits 155: Myriad Genetics Inc. - Product/Service
Exhibits 156: Myriad Genetics Inc. - Key offerings
Exhibits 157: QIAGEN NV - Overview
Exhibits 158: QIAGEN NV - Product/Service
Exhibits 159: QIAGEN NV - Key news
Exhibits 160: QIAGEN NV - Key offerings
Exhibits 161: Siemens AG - Overview
Exhibits 162: Siemens AG - Business segments
Exhibits 163: Siemens AG - Key news
Exhibits 164: Siemens AG - Key offerings
Exhibits 165: Siemens AG - Segment focus
Exhibits 166: Sysmex Corp. - Overview
Exhibits 167: Sysmex Corp. - Business segments
Exhibits 168: Sysmex Corp. - Key offerings
Exhibits 169: Sysmex Corp. - Segment focus
Exhibits 170: Thermo Fisher Scientific Inc. - Overview
Exhibits 171: Thermo Fisher Scientific Inc. - Business segments
Exhibits 172: Thermo Fisher Scientific Inc. - Key news
Exhibits 173: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 174: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 175: Inclusions checklist
Exhibits 176: Exclusions checklist
Exhibits 177: Currency conversion rates for US$
Exhibits 178: Research methodology
Exhibits 179: Validation techniques employed for market sizing
Exhibits 180: Information sources
Exhibits 181: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global companion diagnostics market: Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising occurrence of breast cancer.'

According to the report, one of the major drivers for this market is the rising use of personalized medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.